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Abstract
Background: Shark heavy chain antibody, also called new antigen receptor (NAR), consists of one
single Variable domain (VH), containing only two complementarity-determining regions (CDRs).
The antigen binding affinity and specificity are mainly determined by these two CDRs. The good
solubility, excellent thermal stability and complex sequence variation of small single domain
antibodies (sdAbs) make them attractive alternatives to conventional antibodies. In this report, we
construct and characterize a diversity enhanced semi-synthetic NAR V display library based on
naturally occurring NAR V sequences.
Results:  A semi-synthetic shark sdAb display library with a complexity close to 1e9 was
constructed. This was achieved by introducing size and sequence variations in CDR3 using
randomized CDR3 primers of three different lengths. Binders against three toxins, staphylococcal
enterotoxin B (SEB), ricin, and botulinum toxin A (BoNT/A) complex toxoid, were isolated from
panning the display library. Soluble sdAbs from selected binders were purified and evaluated using
direct binding and thermal stability assays on the Luminex 100. In addition, sandwich assays using
sdAb as the reporter element were developed to demonstrate their utility for future sensor
applications.
Conclusion:  We demonstrated the utility of a newly created hyper diversified shark NAR
displayed library to serve as a source of thermal stable sdAbs against a variety of toxins.
Background
Sharks, similar to camelids, possess unconventional heavy
(H) chain antibodies, consisting of heavy chain
homodimers in which each chain contains one single var-
iable and five constant domains [1,2]. The conserved
amino acid residues between the shark heavy chain anti-
body and those involved in forming the core of immu-
noglobulin and T-cell receptor variable regions, gave
impetus for naming shark heavy chain antibody Immu-
noglobulin New Antigen Receptor (IgNAR or NAR) [2,3].
Structural analysis by electron microscopy, crystal struc-
ture, and 3D modeling revealed that there are three NAR
isotypes. These isotypes are defined according to their pat-
tern of inter-loop disulfide linkages within the variable
region and the timing of their appearance during the ani-
mal's development [3-6].
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Using genetic engineering a single NAR variable (V) anti-
gen-binding domain can be expressed as a separate solu-
ble protein often referred to as a shark single domain
antibody (sdAb). Shark sdAbs contain four conserved
frame regions (FRs) and two complementarity-determin-
ing regions (CDRs), making them the smallest (~12 kD)
Ig-based recognition units with full capacity for antigen
binding affinity and specificity. Due to their small size,
they may be able to access antigen epitopes not generally
recognized by recombinant conventional antibodies [7].
Although both shark and camelid sdAbs share similar
structural features and functional requirements [3], shark
sdAb lack a conventional CDR2, and contain two hyper-
variable regions (HVs), HV2 and HV4, which may con-
tribute to antigen binding [3,8,9]. According to the crys-
tallographic analysis of NAR V structure, the loop of HV2,
located within the FR2-CDR2 region, is located across the
middle of the molecules and may influence the conforma-
tion of the CDR3; moreover, the loop of HV4, located
between HV2 and CDR3, is formed proximal to CDR1
and may influence the antigen binding interactions [3].
Similar to camelid sdAbs, shark sdAbs exhibit excellent
solubility for protein production, superior to many
recombinant conventional antibodies, and retain confor-
mational stability when heated or refold correctly upon
cooling, [10-13]. These intrinsic properties make sdAb
exceptional alternatives for diagnostic applications. Using
phage display technology and PCR amplification, the rep-
ertoire of the naturally occurring NAR V from either
immunized or naïve (non-immunized) animals were
established and used for panning against target antigens
[10,11]. High affinity binders to a specific target were
obtained from immunized libraries however required a
waiting period for suitable immunization to be achieved
and an animal care facility [11]. On the other hand, weak
binders against a wide variety of target antigens were
obtained from naïve libraries; they were selected rapidly
and no immunization period was required [10,14]. If
higher affinity binders are desired than those obtained
from the naïve library, the sdAb can be enhanced using in
vitro affinity maturation [12,15].
It is believed that the diversity of naturally occurring NAR
V results from multiple rearrangements of the CDR genes
and somatic hypermutations in vivo [2]. Consistent with
this finding, the complexity of shark NAR V usually
resides in CDR1 with sequence variation within residues
28–33 and an extended CDR3, which varies in length
(5–23 residues) and in amino acid composition. Routes
to introduce diversity and increase the complexity of naïve
libraries include: variation of CDRs via DNA shuffling
[16], PCR using randomized primers, and random muta-
genesis by error prone PCR [17] or dNTP analogs [18].
Although DNA shuffling, which involves the recombina-
tion of several small DNA fragments within a whole vari-
able region, has been successfully used to create a semi-
synthetic llama library with giga diversity [19], it has not
been used for constructing a more diverse shark display
library due to the short NAR V DNA fragments, less than
400 bp in size. Instead, PCR using randomized CDR3
sequences has been used to construct more diverse syn-
thetic libraries, resulting in binders with higher affinity
and specificity to target antigens [10,12].
Our previously described naïve NAR V library, SP, from
spiny dogfish shark (Squalus acanthias) was successfully
panned for the isolation of binders to cholera toxin; how-
ever our ability to obtain specific binders towards other
targets was disappointing [20]. In this study, we expanded
the utility of the naive display library by introducing vari-
ations in CDR3 amino acid composition and length (13,
16, or 18 residues). In this manner, a semi-synthetic NAR
V display library, SPSL1, with a complexity of ~1e9 was
successfully constructed and used for panning against
ricin, staphylococcal enterotoxin B (SEB) and BoNT/A
complex toxoid. We successfully selected binders against
these three toxins and characterized the purified sdAbs
using ELISA and Luminex 100 assays. Our results suggest
that this new diversified NAR V display library can serve as
a fruitful source of sdAbs against a variety of toxins.
Results and Discussion
Library construction and selections
A semi-synthetic shark display library was constructed
starting with DNA isolated from a naturally occurring
spiny dogfish shark library (SP) by randomizing CDR3.
Most clones in the SP library had loop lengths between 13
to 18 amino acids based on 136 sequences (unpublished
data). Three random primers (Table 1) were used in PCR
reactions with the aim of increasing diversity of the new
shark library by varying the length and residues within
CDR3. These primers are designed to generate CDR3s
with loop lengths of 13, 16, or 18 amino acids to target
the dominant populations. Loop lengths of 14, 15, or 17
Table 1: Randomized oligonucleotide primers used for 
amplification of randomized spNAR V CDR3 sequences.
Direction Number Sequence (5'-3')
Forward Primer mixa #8406, #8407/8, #7554/6, #9686/7, 
forextra
Reverse Primer mixb #6974/7, 7553/5, #9688/9, revextra
Reverse spCDR3 R18 GGTYARWRSGGTKCCAKYTCC(MN
N)18AGYKTTGCARWWAKACGTGGC
Reverse spCDR3 R16 GGTYARWRSGGTKCCAKYTCC(MN
N)16AGYKTTGCARWWAKACGTGGC
Reverse spCDR3 R13 GGTYARWRSGGTKCCAKYTCC(MN
N)13AGYKTTGCARWWAKACGTGGC
a, b were described in detail as in Liu et al. [20].BMC Biotechnology 2007, 7:78 http://www.biomedcentral.com/1472-6750/7/78
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amino acids can be used in the future to introduce more
diversity if necessary. Sequences from 13 random clones
confirmed that CDR3 was composed of 13, 16, or 18 res-
idues with random combinations of amino acids. Among
these clones, 7 out of 13 clones appeared to have full-
length sequences, 2 out of 13 had either frame shifts or
deletion products, and 4 out of 13 clones contained
amber codons. Since each of the 13 clones had a unique
sequence, we estimated that the newly constructed shark
library (SPSL1) contains ~1e9 individual clones, a com-
plexity of ~1e9 with ~8e8 coding for full-length sdAb pro-
teins. Compared to error prone PCR and DNA shuffling,
randomized nucleotides primers generate a higher per-
centage of clones containing amber stop codons within
the CDR3 region. However, since phage were prepared
from an E. coli amber suppressor strain, the full- length
proteins were still displayed on the phage tails during
panning enrichment. Therefore, the presence of amber
codons did not decrease the effective complexity of our
new library.
After three rounds of panning the SPSL1, we observed
mild enrichment (~3-fold) for SEB binding (Fig. 1A) and
strong enrichment (> 10-fold) for ricin. The binding
enrichments from panning SPSL1 for both toxins were
higher than those from panning the naturally occurring
NAR V display library, SP (Figs 1A and 1B). In addition,
we observed a 12-fold enrichment for BoNT/A complex
Polyclonal phage ELISA Figure 1
Polyclonal phage ELISA. Phage pools obtained from panning the new SPSL1 with the three tested toxins and panning the previ-
ously established SP with SEB and ricin were tested for binding specificity using ELISA. After three rounds of panning SPSL1, 
SEB binder phages were enriched approximately three-fold, while no enrichment was observed from panning SP (A). Ricin 
binder phages were enriched over ten-fold after second and third panning of SPSL1 and no enrichment was observed in pan-
ning SP (B). BoNT/A complex toxoid binders were enriched approximately twelve-fold after the first round and there was no 
significant enrichment after the second round. The same amount of the phage from each sample was used for the assay. Data 
were obtained from two independent experiments.BMC Biotechnology 2007, 7:78 http://www.biomedcentral.com/1472-6750/7/78
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toxoid binding after the first SPSL1 panning (Fig. 1C). For
each toxin we screened 96 clones randomly selected from
SPSL1 panning round 2 or 3 using monoclonal phage
ELISA as described in the methods section. From each
selection we sequenced 15 clones that had a ratio of toxin
binding to BSA binding of greater than 3. We obtained
two unique SEB binding sequences, one ricin binding
sequence and two BoNT/A complex toxoid binding
sequences.
Sequence analysis
Ninety-six clones were screened for each selection and fif-
teen potential binders for each toxin were sent out for
sequencing. Unique toxin binding sequence(s) were ana-
lyzed using ClustalW [21] (Fig. 2). The two BoNT/A com-
plex toxoid binders, P4BH8 and P4BF7-3, varied
significantly in amino acid composition within the four
hypervariable regions, suggesting they target different
epitopes. Interestingly, they both showed similar binding
reactivity toward BoNT complex toxoid subtypes (Fig.
2A). The SEB binders, P2SC8 and P1SD3-3, shared identi-
cal CDR1, HV2, and conserved arginine within CDR3 but
varied in amino acid 61 within the HV4 region (Fig. 2B).
The two SEB binders along with the BoNT/A complex tox-
oid binder, P4BF7-3, had no formation of inter-loop
disulfide bonds and shared a conserved W31 within
CDR1, which are major features of type 3 NAR V origi-
nally defined as appearing only in juvenile nurse sharks
less than one year old [5,18]. Previously, we discovered
that our spiny dogfish NAR V display library derived from
adult animals over one year old contained approximately
Sequences of isolated toxin binding sdAb Figure 2
Sequences of isolated toxin binding sdAb. Fifteen potential binders for each tested target were sequenced. The resulting unique 
sequences were decoded into amino acid sequences, which were aligned using ClustalW and compared. Two BoNT/A com-
plex toxoid binders had common R32, T33 in CDR1 (residue 28–35); E47, R48, I49, S50, I51 in HV2 (residue 44–53); K61 in 
HV4 (residues 61–65); and R92 in CDR3 (residues 86–101) (A). Two SEB binders shared identical CDR1, similar HVs except 
residues 4 and 61, and two conserved residues, R92 and R93 in CDR3 (residues 86–98) (B). The ricin binder had C33 in CDR1 
and 16 residues in CDR3 (C). The homologous residues between binders were labeled with "*" and similar substitution with 
":"and '.'. The CDRs and hyper variable regions are indicated within the box area. The invariant W31 within CDR1 in type 3 
NAR V is in bold and underlined.BMC Biotechnology 2007, 7:78 http://www.biomedcentral.com/1472-6750/7/78
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7% of type 3 NAR V fragments. This may be a unique fea-
ture of spiny dogfish shark [20]. These type 3 spiny dog-
fish shark NAR V differ from ones found in nurse shark,
since they exhibited more diverse length and composition
with or without a conserved F96 in CDR3 [5,20,22].
Amino acid composition has a great influence on confor-
mation and stability. As the spiny dogfish shark type3
NAR V binders lack the invariant aromatic Y86 and F96
found to participate in forming more rigid CDR3 loops,
they likely exhibit different CDR conformational plastic-
ity than type3 NAR V from nurse sharks [22]. Ricin binder,
P4RA7-1 is an atypical type 2 NAR V with no formation of
inter-loop disulfide bonds due to the lack of Cys in the
CDRs (Fig. 2C). One of the BoNT/A complex toxoid bind-
ers, P4BH8, is an atypical type 1 NAR V that lacks Cys res-
idues in FR2 and FR4 but contains two CDR3 Cys
residues, which allows the formation of an intra-loop
disulfide bridge to stabilize CDR conformation. The
mechanism of CDR conformation stability for these atyp-
ical NAR V should be different from their corresponding
typical NAR V and is a topic for future investigation. It is
likely that HV2 and HV4 may play extremely dominant
roles to stabilize CDR conformation [3,8,23].
Expression of soluble monomeric SdAbs
Five selected binders were sub-cloned to the pEcan 22
expression plasmids, a gift from Dr. Andrew Hayhurst, for
overproduction [24]. Monomeric soluble protein was
purified using a nickel affinity column followed by gel fil-
tration [20]. Expression levels for these five binders var-
ied. Yields for P4BH8, P4BF7-3, and P4RA7-1 were about
1.0 mg per liter of bacterial culture; this is similar to the
yield of hen egg white lysozyme binders isolated from a
repertoire of nurse shark NAR V [11]. The production
amounts for the two SEB binders, P1SD3-3 and P2SC8,
were about 6-fold less. The difference in expression levels
may be due to overall conformation stability and domain
surface charges resulting from sequence and structural
diversity. However, we did not observe a good correlation
pattern between the clone sequences and the expression
levels based on the comparison of amino acid residues.
Structural and 3D modeling studies for these clones are
required to reveal more information about correlations
between protein expression level and sequence variation.
Direct binding to determine affinity and specificity
Binding affinity and specificity was determined using
direct binding assays with toxoid-coated and toxin-coated
microspheres as described in the methods. The equilib-
rium constant (kd) for each sdAb and conventional anti-
body was calculated from direct binding curves using the
formula, y = (Bmax)x/(Kd+x) (Table 2). This calculation
let us compare the sdAb and conventional antibodies.
Overall, the affinities of the selected binders were in the
100's of nM, many times that of conventional antibody,
however they could be used as scaffolds for further affinity
maturation studies (Table 2).
The isolated ricin binder, P4RA7-1, bound specifically to
intact ricin and ricin A relative to irrelevant targets, CT,
BoNT/A complex toxoid and SEB, suggesting it is a ricin A
chain binder (Fig. 3A). Its superior specificity makes it an
ideal candidate for further affinity maturation. One of the
BoNT/A complex toxoid binders (P4BF7-3) was fairly spe-
cific to BoNT complex toxoid subtypes, but the other
(P4BH8) showed significant non-specific binding to ricin
and CT (Figs. 3B and 3C). The measurement of direct
binding for the ricin binder (Fig. 3A) and CT binders iso-
lated previously [20] (data not shown) to microspheres
with BoNT complex toxoids immobilized to their surface
showed no significant interaction, indicating that the
sdAb do not as a class nonspecifically bind BoNT complex
toxoids. Thus, the non-specific binding observed for any
binder selected appears to be intrinsic to just that sdAb,
however it points out the necessity to critically evaluate
specificity for binders derived by this or similar methods.
Nonetheless, for the BoNT binders selected, both had
stronger binding to the three tested BoNT complex toxoid
subtypes, E, B, and A than to irrelevant targets (Fig. 3B).
Generally, they appeared to bind subtypes E and B even
more than A (Figs. 3B and 3C), suggesting that toxoid
complexes derived by formalin-inactivation may share
some common epitopes among subtypes (Figs 3B and
3C). Since P4BF7-3 specifically cross-reacts to other com-
plex toxoid subtypes it may be useful for generic BoNT
detection, as opposed to subtype classification. The anti-
BoNT sdAb were also tested for their binding to a range of
BoNT subtypes using the various toxins as wells as their
toxoids immobilized on microspheres. Both BoNT/A
binders showed considerable cross-reactivity to other
Table 2: Equilibrium dissociation constants
Ricin Kd (nM)
sdAb-P4RA7-1 299 ± 49
Cy3-Rab-Anti-Ricin IgG 50.0 ± 7.5
SEB
sdAb-P1SD3 10.2 ± 7.2
sdAb-P2SC8 107 ± 38
Cy3-sh-anti-SEB IgG 3.6 ± 3.6
BoNT/A complex toxoid
sdAb-P4BF7-3 154 ± 26
sdAB-p4BH8 390 ± 90
Rab-anti-BoNT 0.02 ± 0.003
BoNT/B complex toxoid
sdAb-P4BF7-3 106 ± 22
sdAb-P4BH8 332 ± 68
Rab anti-BoNT 0.05 ± 0.007
BoNT/E complex toxoid
sdAb-P4BF7-3 93 ± 18
sdAb-P4BH8 309 ± 75BMC Biotechnology 2007, 7:78 http://www.biomedcentral.com/1472-6750/7/78
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BoNT subtypes; this binding was significantly greater than
binding to irrelevant targets (preliminary data not
shown). To obtain specific BoNT/A toxin binders, more
library screening may be necessary; however these selected
binders may find use for sample enrichment purposes, a
critical need for such a potent toxin.
The SEB binders showed very different binding affinity
and specificity despite their identical CDR1 and homolo-
gous CDR3 sequences (Figs. 2B, 3D and 3E). P1SD3-3
bound to SEB specifically relative to irrelevant targets,
while P2SC8 exhibited more non-specific sticky interac-
tions with irrelevant targets, CT and ricin (Figs 3D and
3E). Moreover, P1SD3-3, has ten-fold better binding
affinity (kd  = 10.2 nM) than P2SC8 (kd  = 106.8 nM)
(Table 2). A recent affinity maturation study showed that
changing S61 to R61 within the HV4 in nurse shark NAR
V contributed to increased binding affinity resulting from
more van der Waals' contacts on the mature sdAb [8]. The
change of K61 to E61 within HV4 in P1SD3-3 might
exhibit a similar effect and perhaps resulted in observed
higher binding affinity and specificity of P1SD3-3 com-
pared to P2SC8 (Fig. 2B, Figs. 3D and 3E). P2SC8 and
P4BF7-3 had identical sequences for most regions except
CDR3 and amino acid 48 in HV2. The resulting differen-
tial binding reactivity to all tested toxins suggests that
CDR3 alone may play a major role to determine the bind-
ing specificity in these two clones.
Thermal stability determinations
Our results indicated that the ricin binder showed better
thermal stability than polyclonal antibody, and was simi-
Luminex direct binding assay Figure 3
Luminex direct binding assay. Microspheres with covalently attached toxins and irrelevant targets were mixed with purified 
sdAbs at concentrations of 0, 3.4, 10.9, 30.9, 92.6, 277.8, 833.3, and 2500 nM to test the binding affinity. Microspheres were 
sorted using the Luminex 100 and the median fluorescence signals were obtained. The ricin binder showed that a maximal 
binding concentration (Vmax) for ricin and ricin A was around 300 nM with < 0.1% of non-specific binding to ricin B, CT, SEB 
and BoNT/A complex toxoid (A). BoNT/A complex toxoid binders, P4BF7-3 and P4BH8, exhibited the same Vmax. P4BF7-3 
had approximately 13% and 25% of the non-specific binding signal to CT and ricin, respectively (B) and P4BH8 had even higher 
non-specific binding signals than P4BF7-3 (C). SEB binder P1SD3-3 had Vmax around 10.9 nM with less than 1% of non specific 
binding signals to CT and ricin (D), while P2SC8 had Vmax around 300 nM with more than 30% of non-specific binding signals 
(E).BMC Biotechnology 2007, 7:78 http://www.biomedcentral.com/1472-6750/7/78
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lar in stability to the monoclonal antibody tested (Fig.
4A). Upon heating, the ricin binder still retained its specif-
icity showing insignificantly binding to irrelevant targets,
CT and SEB (Fig. 4B). Both BoNT/A complex toxoid bind-
ers retained a substantial amount (60%–80%) of the orig-
inal binding activity after being heated for 60 min at
85°C, while non-specific binding was actually reduced
over the same period (Figs 4D and 4E). Overall, they
showed much better thermal stability than conventional
antibody, which lost activity rapidly upon heating (Figs,
4C, 4D and 4E).
Of the two, P4BF7-3 appeared to be more stable than
P4BH8 (Fig. 4C), suggesting that it might have a more sta-
ble CDR conformation. The conformational stability may
partially result from the formation of an intra-loop
disulfide bridge within CDR3 (Fig. 2A). Interestingly,
P4BH8, showed 30% more than initial binding reactivity
to target, upon heating for 5 min (Fig. 4C). This phenom-
enon is often seen in sdAbs, possibly due to better binding
of the refolded structure that results from a short period of
heating and rapid cooling; this same phenomenon may
also be the cause for improvements in specificity
[12,13,20].
Both SEB binders exhibited better thermal stability than
tested conventional antibodies (Fig. 4F). They showed
similar thermal stability profiles, suggesting both share a
similar CDR conformation resulting from similar
sequences (Fig. 2B).
Thermal stability assay Figure 4
Thermal stability assay. Antibodies were heated at 85°C for various time points up to 60 min and cooled down prior to meas-
uring binding affinity and specificity using luminex direct binding assays. Each antibody at a concentration of maximal binding 
mentioned in Fig. 3 was used for this thermal stability assay. Mab-Ric07AG1, and ricin binder, P4RA7-1, retained 60% and 40% 
of the original activity, respectively; while Cy3-Rab anti-Ricin had only 10% of remaining activity upon 5 min of heating (A). Dur-
ing the heating, P4RA7-1 binding to irrelevant targets, CT and SEB, was insignificant. (B). After 5 min of the heating, P4BH8 and 
P4BF7-1 had 130% and 60% of the untreated activity, while Rab anti-BoNT/A retained 20% of the untreated activity. Upon 60 
min of heating, both retained 60%–80% of untreated activity, while Rab anti-BoNT/A lost almost 100% of the initial activity 
within the first 10 min of heating. (C). P4BH8 decreased 75% of the initial non-specific binding to ricin after 15 min of heating 
(D). P4BF7-1 decreased 50–60% of the initial non-specific binding to irrelevant target(s), ricin and CT, after 10 min of heating 
(E). Both P1SD3-3 and P2SC8 retained about 55% of the initial activity after 5 min of heating, while two conventional antibod-
ies, Mab 2b3a, and Mab 6b, lost about 90–95% of the initial activity (F).BMC Biotechnology 2007, 7:78 http://www.biomedcentral.com/1472-6750/7/78
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Use of sdAb as reporter reagents in sandwich assays
Sandwich assays using sdAb in conjunction with Ni-SA-PE
as tracer reagents were performed as detailed in the meth-
ods. Capture antibodies including irrelevant antibody as a
negative control, conventional antibodies and sdAbs were
used. Ricin binder, P4RA7-1, was able to detect ricin at a
concentration of 1 μg/mL, using monoclonal antibody or
llama sdAb Ric E7 as the capture reagents and showed no
binding to the negative control beads coated with CT anti-
body, Lx-CT-C11 (Fig. 5A). For BoNT sandwich assays,
llama anti-BoNT was used as the capture reagent for either
BoNT/A or B complex toxoids, which was subsequently
detected at a concentration of 40 ng/mL by P4BF7-3 using
Ni-SA-PE to generate signal (Figs. 5B and 5C). As might be
expected, the Rab anti BoNT/A showed good selectivity,
capturing BoNT/A complex toxoid, but not B complex
toxoid (Fig. 5B and 5C). For SEB sandwich assays, the spe-
cific SEB binder, P1SD3-3 was used as a tracer and could
detect SEB at a concentration of 10 ng/mL with insignifi-
cant non-specific signal observed on the control micro-
spheres (Fig. 5D). In general, we were able to demonstrate
the use of sdAbs as reporter reagent in sandwich assays.
Luminex Sandwich assay Figure 5
Luminex Sandwich assay. To measure the utility of sdAbs as tracer antibody, luminex sandwich assays were conducted. Purified 
antibodies for each tested target along with Ni-SA-PE were mixed with toxins captured by microspheres coated with the cap-
ture antibodies. Mab-Ric 03, llama sdAb Ric E7, and llama sdAb CT-C11 (as negative control) were used to capture ricin, which 
was at concentrations of 0.1–10 μg/mL. Ricin binder, P4RA7-1, along with Ni-SA-PE were used as a tracer and were able to 
detect ricin at 1 μg/mL captured by Mab-Ric 03 and llama sdAb Ric E7, but not negative control (A). Llama anti-BoNT, Lx-Rab-
anti-BoNT/A and Lx-Rab anti-SEB (negative control) were used to capture BoNT/A complex toxoid, which was at concentra-
tions between 0.1 to 200 ng/mL. P4BF7-3 and Ni-SA-PE were used as tracers to detect BoNT/A complex at a minimum con-
centration of 40 ng/mL captured by Llama anti-BoNT, Lx-Rab-anti-BoNT/A, but not Lx-Rab anti-SEB (B). The same tracers 
were used to detect BoNT/B complex toxoid at a concentration of 40 ng/mL captured by only Llama anti-BoNT, but not by 
Lx-Rab-anti-BoNT/A or Lx-Rab anti-SEB (C). Mouse monoclonal antibody against SEB, Mab2b3a, and Rab anti-Ricin (negative 
control) were used to capture SEB, at concentrations range from 0.01 to 100 ng/mL. P1SD3-3 and Ni-SA-PE were used as 
tracer to detect the SEB at a minimum concentration of 10 ng/mL, captured by Mab2b3a, but not by Rab anti-Ricin (D).BMC Biotechnology 2007, 7:78 http://www.biomedcentral.com/1472-6750/7/78
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Conclusion
The sdAbs selected from the new randomized naïve shark
library exhibit serviceable specificity and excellent ther-
mal stability, but their binding affinity was weaker than
the conventional antibodies tested. Often, affinity matu-
ration is required to obtain high affinity binders. Besides
the common approaches described in the background sec-
tion, 3D structural modeling also provides a powerful tool
to reveal more detailed information regarding the change
of amino acids within the constant regions and HVs [9].
However, the typical increase in binding affinity has been
only 10-fold using these approaches, which would still
not produce binders comparable to the best conventional
antibodies [9]. Alternatively, multiple copies of sdAbs
against the same target can be linked together to generate
high avidity structures [2,25,26], which can result in three
orders of magnitude higher affinity than the monomeric
sdAb. This may be a more attractive way to improve bind-
ing reactivity for our sdAb (Table 2).
In the future, we may need to introduce more variation in
the CDR3 loop length in combination with the preferred
insertion of Cys into defined CDR3 positions. Construc-
tion of a more diverse library, containing a greater per-
centage of conventional type 1 and 2 NAR sequences may
allow us to obtain specific binders for each BoNT subtype
for detection purpose. Nevertheless, our results indicated
that the new semi-synthetic shark library had better CDR3
diversity and better utility than our previously established
naturally occurring NAR V display library, suggesting this
may be the correct path towards obtaining a limitless
source of sdAbs against a variety of toxins for sensor appli-
cations.
Methods
Library construction
DNA template was isolated from the naturally occurring
shark library using the plasmidpure DNA miniprep kit
(Sigma, St. Louis, MO) and was used to amplify rand-
omized CDR3 fragments with forward primer mix and
randomized reverse primers (table 1). PCR condition was
as follows: 94°C for 30s, 55°C for 90s, and 70°C for 30s,
and 35 amplification cycles. The resulting 400 bp PCR
products were then used as templates to amplify the full
length NAR V fragments flanked with SfiI and NotI restric-
tion sites on 5' and 3' respectively using forward and
reverse primer mixes [17]. The full length NAR V frag-
ments and pHen2 plasmids were then cut with SfiI and
NotI, followed by overnight ligation at 15°C. The ligation
mixture was cleaned by Qiagen PCR kit (Qiagen, Valencia,
CA) and subjected to electroporation using XL 1 Blue cells
(Strategene, La Jolla, CA). The cells were plated on big
Nunc Bio-assay dishes containing LB agar, 2% glucose,
and 100 μg/mL ampicillin and grown overnight. The
transformed bacteria were scrapped and stored at -80°C
the next day. The resulting semi-synthetic library was
named SPSL1.
Toxin binder selection by panning and ELISA
Panning and ELISA assays were carried out essentially as
described previously [20]. Ricin, SEB and BoNT/A com-
plex toxoid at concentrations of 10 μg/mL were passively
immobilized on high binding 96 well plates and used to
mine the semi-synthetic shark NAR V display library,
SPSL1, in 3 rounds of panning. Polyclonal phage ELISAs
on target and control antigens were used to identify
rounds in which clones had been successfully enriched.
Monoclonal ELISAs were subsequently used to identify
monoclonal sdAbs [20]. Typically, 15 antigen positive
clones were subjected to DNA sequencing to identify
unique clones.
Expressing and purifying sdAb
NAR V fragments isolated from potential binders were cut
with SfiI and NotI. The resulting fragments were inserted
into pEcan 22 vectors and transformed into the E. coli
Tuner strain for protein expression. Expressed protein was
purified by osmotic shock from Tuner cultures, immobi-
lized metal affinity chromatography, and gel filtration
[20,27].
Characterizing purified sdAb by Luminex 100 
immunoassays
For direct binding assay, Luminex microspheres coated
with relevant and irrelevant toxins were incubated with
purified sdAbs at the concentrations of 0.01–2500 nM for
30 min, followed by the addition of fluorescent tracer, Ni-
streptavidin-phycoerythrin (Ni-SA-PE). For thermal sta-
bility testing, purified sdAb proteins and control antibod-
ies were heated to 85°C for 60 min with samples removed
to cooling at various time points and analyzed for antigen
binding activity. In all analyses, sdAb binding to irrelevant
antigens was also monitored to ensure signal was not due
to non-specific binding of unfolded sticky protein. For
sandwich assay, Luminex microspheres with antibodies
immobilized were mixed with target antigens. Then a sec-
ond sdAb, and Ni-SA-PE were added into the reaction to
measure the binding of captured antigens. The prepara-
tion of immuno-reagents was described previously [19].
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